These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 12583353

  • 1. Cardiovascular thrombotic events and COX-2 inhibitors: results in patients with osteoarthritis receiving rofecoxib.
    Bannwarth B, Ravaud P, Dougados M.
    J Rheumatol; 2003 Feb; 30(2):421-2. PubMed ID: 12583353
    [No Abstract] [Full Text] [Related]

  • 2. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.
    Weir MR, Sperling RS, Reicin A, Gertz BJ.
    Am Heart J; 2003 Oct; 146(4):591-604. PubMed ID: 14564311
    [Abstract] [Full Text] [Related]

  • 3. [COX-2 inhibitor in arthrosis. Discontinuation before operations not necessary].
    MMW Fortschr Med; 2001 Oct 18; 143(42):64. PubMed ID: 11697296
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. An update on specific COX-2 inhibitors: the COXIBs.
    Gupta S, Crofford LJ.
    Bull Rheum Dis; 2001 Oct 18; 50(1):1-4. PubMed ID: 12092091
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [A new pharmacological principle is effective--rofecoxib. Specific COX-2 inhibition].
    MMW Fortschr Med; 1999 Dec 16; 141(51-52):66-7. PubMed ID: 10949630
    [No Abstract] [Full Text] [Related]

  • 9. [New study of selective COX-2 inhibitors. Protecting the stomach while risking the heart? (interview by Dr. Beate Schumacher)].
    Zeidler H.
    MMW Fortschr Med; 2001 Sep 06; 143(35-36):14. PubMed ID: 11584521
    [No Abstract] [Full Text] [Related]

  • 10. Anaphylactoid reaction to a cyclooxygenase-2 inhibitor in a patient who had a reaction to a cyclooxygenase-1 inhibitor.
    Schellenberg RR, Isserow SH.
    N Engl J Med; 2001 Dec 20; 345(25):1856. PubMed ID: 11752370
    [No Abstract] [Full Text] [Related]

  • 11. Adverse Drug Events Involving COX-2 Inhibitors.
    Verrico MM, Weber RJ, McKaveney TP, Ansani NT, Towers AL.
    Ann Pharmacother; 2003 Sep 20; 37(9):1203-13. PubMed ID: 12921500
    [Abstract] [Full Text] [Related]

  • 12. [When dental extraction or surgical intervention is anticipated. Coxib decreases postoperative pain].
    MMW Fortschr Med; 2003 Feb 13; 145(7):63. PubMed ID: 12652831
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
    Ray WA, MacDonald TM, Solomon DH, Graham DJ, Avorn J.
    Pharmacoepidemiol Drug Saf; 2003 Feb 13; 12(1):67-70. PubMed ID: 12616850
    [No Abstract] [Full Text] [Related]

  • 15. COX-2 and COX-2 enzyme inhibition.
    Conti P.
    Int J Immunopathol Pharmacol; 2003 Feb 13; 16(2 Suppl):I-II. PubMed ID: 14552697
    [No Abstract] [Full Text] [Related]

  • 16. Differences between COX-2-specific inhibitors: clinical and economic implications.
    Sonnenblick EH.
    Am J Manag Care; 2002 Oct 13; 8(15 Suppl):S428-30. PubMed ID: 12416792
    [No Abstract] [Full Text] [Related]

  • 17. Interactions between aspirin and COX-2 inhibitors or NSAIDs in a rat thrombosis model.
    Umar A, Boisseau M, Yusup A, Upur H, Bégaud B, Moore N.
    Fundam Clin Pharmacol; 2004 Oct 13; 18(5):559-63. PubMed ID: 15482377
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.